vimarsana.com

Page 3 - அடார் பூனாவல்ல சீரம் நிறுவனம் ஆஃப் இந்தியா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cong assures security to Adar Poonawalla, urges him to name leaders who made threat calls

Cong assures security to Adar Poonawalla, urges him to name leaders who made threat calls ANI | Updated: May 03, 2021 12:55 IST Mumbai (Maharashtra) [India], May 3 (ANI): A day after Adar Poonawalla, the CEO of Serum Institute of India (SII) reportedly said that he received threats from powerful people for the delivery of vaccines, Maharashtra Congress chief Nana Patole urged Poonawalla to make the names of those leaders public, adding that his party takes full responsiblity for his security. Speaking to reporters here today, Patole said, Adar Poonawalla (Serum Institute of India CEO) said that he was threatened by some senior leaders. Congress takes full responsibility for his security. But he should make it public as to who are these leaders.

Is India s vaccine diplomacy hurting its fight against Covid?

Is India s vaccine diplomacy hurting its fight against Covid? TIMESOFINDIA.COM / Updated: Apr 8, 2021, 10:52 IST (This story was first published in The Times Of India on April 8, 2021) New Delhi: Is there a shortage of Covid-19 vaccines for India s inoculation drive? Should vaccination be opened up for all, irrespective of age, ailments or professional engagement? Has India s vaccine diplomacy posed a hurdle in its own fight against the pandemic? Despite two vaccines in mass production and an ambitious nationwide immunisation programme under way, the Centre has been grappling with pointed questions from some states as well as experts about its vaccination strategy and the supply of doses.

AstraZeneca legal notice to Serum Institute over delays

URL copied AstraZeneca legal notice to Serum Institute over delays. Adar Poonawalla s Serum Institute of India (SII) has been served a legal notice by AstraZeneca over delays in supplying the Covid vaccine. Poonawalla has mentioned that the existing production capacity to manufacture Covishield in India is under pressure due to increased demand in India. Poonawalla has also mentioned as per reports that the Indian government s pause on major Covishield shipments to other countries and the first claim deal with India were difficult to explain abroad, where the vaccine was sold at a higher cost per dose. In March, AstraZeneca had announced supply to 142 countries underway as part of the unprecedented effort to bring broad and equitable access to the vaccine.

AstraZeneca Legal Notice To Serum Institute Over Vaccine Delays: Sources

AstraZeneca Legal Notice To Serum Institute Over Vaccine Delays: Sources
ndtv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ndtv.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.